Hola,
¿eres nuevo aquí?

Registrate y conecta tu empresa con financiación pública, partners y proyectos.

FluoNeeD

Financiado

Fluorinated Lipid Nanoparticles for Gene Delivery and Diagnostics

The formulation of drug nanocarriers has attracted increasing attention over the last decades. In particular, the possibility to combine therapeutic and imaging functionalities in a single nanoplatform (theranostic) has been widel... ver más

31/08/2026

POLIMI

212K€

Presupuesto del proyecto: 212K€

Líder del proyecto

POLITECNICO DI MILANO No se ha especificado una descripción o un objeto social para esta compañía.

TRL 4-5

Ver 3 Participantes

Financiación concedida El organismo HORIZON EUROPE notifico la concesión del proyecto el día 2023-04-28

Línea de financiación objetivo El proyecto se financió a través de la siguiente ayuda:

HORIZON-MSCA-2022-PF-01-01: MSCA Postdoctoral Fellowships 2022

I+D

Cerrada hace 2 años

0% 100%

3 Participantes

POLIMI

212.16K€ | Lider

ASTRAZENECA AB

N.D. | Participante

FINCB

N.D. | Participante

Proyectos interesantes

CodeSphere CodeSphere Discovering Therapeutic Nanoparticles by Molecu... 150K€ Cerrado

PID2021-124247OB-C22 TRANSPORTADORES DE ADN/ARN DE NUEVA GENERACION:CAPSIDES MOLE... 85K€ Cerrado

PNANOMED Personalized Nanomedicines for Leukemia Patients 1M€ Cerrado

JCI-2009-04950 Nanomaterials for drug delivery, gene delivery and imaging 101K€ Cerrado

CTQ2008-02796 SINTESIS DE NANOSISTEMAS DENDRITICOS PARA APLICACIONES EN BI... 113K€ Cerrado

BES-2010-030593 MODIFICACION DE CAPSIDAS VIRICAS POR INGENIERIA DE PROTEINAS... 43K€ Cerrado

Últimas noticias

27-11-2024: Videojuegos y creaci... Se abre la línea de ayuda pública: Ayudas para la promoción del sector del videojuego, del pódcast y otras formas de creación digital

27-11-2024: DGIPYME En las últimas 48 horas el Organismo DGIPYME ha otorgado 1 concesiones

27-11-2024: FUNDACION-EOI En las últimas 48 horas el Organismo FUNDACION EOI ha otorgado 2 concesiones

Duración del proyecto: 40 meses Fecha Inicio: 2023-04-28
Fecha Fin: 2026-08-31

Líder del proyecto

POLITECNICO DI MILANO

TRL 4-5

Presupuesto del proyecto 212K€

Descripción del proyecto The formulation of drug nanocarriers has attracted increasing attention over the last decades. In particular, the possibility to combine therapeutic and imaging functionalities in a single nanoplatform (theranostic) has been widely explored to advance therapeutic approaches and promote the transition from conventional medicine to personalized medicine. Drug nanocarriers, holding the potential to produce a revolution in medicine, are lipid nanoparticles (LNPs) for gene delivery. They have proven versatility and efficacy even though today it is still not possible to predict and control their cellular uptake and targeted delivery. One of the main unmet challenges of LNP formulations is increasing their cellular uptake and gene release into the cytosol. Currently, it is possible to follow the fate of LNPs after administration only with the addition of labels (e.g., fluorophore) or specific ribonucleic acid (RNA) sequence encoding for fluorescent protein. This results in the lack of possibility to follow the fate of LNPs once administered in vivo with a non-invasive imaging technique. Theranostic strategies to deliver RNA and simultaneous imaging of target organs is an important unmet goal. Recently, it has been demonstrated that fluorination of components in gene delivery vehicles strongly improved their cellular uptake and, most importantly, their gene endosomal escape. The fluorination strategies investigated so far use either -CF3 groups or long linear perfluoroalkyl chains, but a tailored design of the fluorinated group could also endow the nanocarrier with excellent imaging functions. In this context, FluoNeeD strategy is to tailor fluorination of LNPs in order to: (i) improve their therapeutic efficacy by enhancing LNP cellular uptake and promoting gene endosomal escape; (ii) render LNPs trackable in vivo by 19F-MRI and in vitro/ex vivo by Raman microscopy.

Conecta tu I+D

Entra hoy

Financiación

Empresas

CTIs/Universidades

Proyectos

Investigadores